BioLargo Inc (BLGO)

OTC Markets

Currency in USD

0.1147

0.0000(0.00%)

Delayed Data·09/07

Fair Value

Unlock Value

Day's Range

0.1065

0.1201

52 wk Range

0.0950

0.2337

BLGO Income Statement

Assess the BioLargo income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the BLGO net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

2.53

5.88

12.23

17.78

7.77

Total Revenues Growth

aa.aa

+4.07%

+132.48%

+107.85%

+45.37%

-56.32%

Cost Of Revenues

aa.aa

1.43

3.03

6.08

9.93

4.36

Gross Profit

aa.aa

1.1

2.86

6.15

7.85

3.41

Gross Profit Growth

aa.aa

-10.18%

+159.02%

+115.4%

+27.61%

-56.63%

Gross Profit Margin %

aa.aa

43.58%

48.56%

50.32%

44.17%

43.86%

Other Operating Expenses, Total

aa.aa

7.52

7.99

10.35

12.18

18.25

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-13.57%	+6.22%	+29.62%	+17.69%	+49.76%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.37	1.32	2.28	2.88	2.59
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.17	6.73	8.06	9.3	15.65
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.02	-0.06	0.01	-	-

Operating Income

aa.aa

-6.42

-5.13

-4.2

-4.33

-14.84

Operating Income Growth

aa.aa

+14.13%

+20.04%

+18.15%

-3.14%

-242.67%

EBIT Margin %

aa.aa

-253.5%

-87.19%

-34.33%

-24.36%

-191.13%

Net Interest Expenses

aa.aa

-0.23

-0.05

-0.09

-0.03

-0.34

Net Interest Expenses Growth

aa.aa

+87.83%

+77.35%

-71.7%

+63.74%

-930.3%

Interest Expense, Total

aa.aa

-0.23

-0.05

-0.09

-0.07

-0.54

Interest And Investment Income

aa.aa

0.04

0.2

Other Non Operating Expenses, Total

aa.aa

0.06

0.07

0.04

-0.08

0.01

EBT, Excl. Unusual Items

aa.aa

-6.6

-5.11

-4.25

-4.44

-15.18

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-0.3

-0.02

-0.39

0.1

-0.01

EBT, Incl. Unusual Items

aa.aa

-6.89

-5.13

-4.65

-4.35

-15.19

EBT, Incl. Unusual Items Growth

aa.aa

+28.93%

+25.56%

+9.43%

+6.48%

-249.41%

EBT, Incl. Unusual Items Margin

aa.aa

-272.38%

-87.22%

-38%

-24.45%

-195.61%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-6.89

-5.13

-4.65

-4.35

-15.19

Minority Interest

aa.aa

-0.19

0.66

1.14

1.95

3.41

Net Income

aa.aa

-7.08

-4.47

-3.5

-2.4

-11.78

Net Income Growth

aa.aa

+16.03%

+36.82%

+21.66%

+31.45%

-390.42%

Net Income Margin %

aa.aa

-279.73%

-76.02%

-28.65%

-13.51%

-151.71%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-7.08

-4.47

-3.5

-2.4

-11.78

Basic EPS - Continuing Operations

aa.aa

-0.03

-0.02

-0.01

-0.04

Basic EPS - Continuing Operations Growth

aa.aa

+33.43%

+41.79%

+26.5%

+34.24%

-376.31%

Diluted EPS - Continuing Operations

aa.aa

-0.03

-0.02

-0.01

-0.04

Diluted EPS - Continuing Operations Growth

aa.aa

+33.43%

+41.79%

+26.5%

+34.24%

-376.31%

Basic Weighted Average Shares Outstanding

aa.aa

247.2

268.3

285.96

298.12

306.95

Diluted Weighted Average Shares Outstanding

aa.aa

247.2

268.3

285.96

298.12

306.95

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-6.4

-5.09

-4.1

-4.18

-14.7

EBITDA Growth

aa.aa

+13.73%

+20.5%

+19.45%

-1.95%

-251.92%

EBITDA Margin %

aa.aa

-252.71%

-86.42%

-33.49%

-23.49%

-189.26%

EBIT

aa.aa

-6.42

-5.13

-4.2

-4.33

-14.84

* In Millions of USD (except for per share items)

FAQ

What was BioLargo’s revenue at year end?

At the end of the last reported fiscal year, BioLargo (BLGO) recorded total revenue of 7.7650 million USD.

How much revenue did BioLargo report in the most recent quarter?

In its most recent quarterly earnings report, BioLargo posted revenue of 1.1150 million USD.

What was BioLargo’s net income for the year?

For the full year, BioLargo reported net income of -11.7800 million USD.

How much net income did BioLargo post in the last quarter?

In the most recent quarter, BioLargo (BLGO) posted net income of -2.2860 million USD.

What was BioLargo’s gross profit for the year?

Gross profit for the year was reported at 3.4060 million USD.

How much gross profit did BioLargo generate last quarter?

BioLargo recorded gross profit of 0.4580 million USD in its latest quarterly report.

What was BioLargo’s annual operating income?

For the full year, BioLargo (BLGO) reported operating income of -14.8410 million USD.

What was BioLargo’s operating income last quarter?

Quarterly operating income was -3.2040 million USD.

What was BioLargo’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -3.1420 million USD.

What was the quarter-over-quarter change in EBITDA for BioLargo?

EBITDA changed by 20.7366% million USD compared to the last quarter.

What is BioLargo’s most recent gross profit margin?

The latest reported gross profit margin for BioLargo (BLGO) is 41.0762% million USD.

What is BioLargo’s most recent net income margin?

Net income margin based on recent financials is -205.0224% million USD.

What is BioLargo’s most recent EBIT margin?

BioLargo reported an EBIT margin of -287.3542% million USD based on current figures.

How did BioLargo’s revenue change compared to the previous quarter?

Revenue changed by 80.7131% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for BioLargo?

In the latest quarter, gross profit changed by 257.8125% million USD from the previous quarter.

S&P/TSX

35,203.22

+2.77

+0.01%

S&P/TSX 60

2,075.71

+2.03

+0.10%

US 30

52,612.70

+125.3

+0.24%

US 500

7,563.50

+19.9

+0.26%

S&P 500 VIX

15.33

-0.51

-3.22%

DAX

25,085.42

-32.85

-0.13%

Dollar Index

100.645

-0.041

-0.04%

Market Movers

Name	Last	Chg. %	Vol.
Toronto Dominion Bank	169.39	+0.49%	1.86M
Aritzia	159.22	+6.87%	1.14M
Bank of Nova Scotia	123.34	+1.18%	1.07M
Shopify Inc	173.95	-0.29%	763.38K
RBC	297.01	+0.40%	640.54K
Canadian Imperial Bank	165.69	+1.32%	624.93K
Bank of Montreal	252.43	+0.73%	410.45K

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Pharmadrug	0.0100	+100.00%	100.00K
ePlay Digital	0.010	+100.00%	7.00K
1933 Industries	0.0100	+100.00%	55.00K
iAnthus Capital	0.01	+100.00%	302.53K

Name	Last	Chg. %	Vol.
Digital Asset Tech	0.01	-66.67%	5.89K
Armada Mercantile Ltd	0.165	-59.76%	1.50K
Martello Tech	0.0050	-50.00%	99.10K
Albert Labs International	0.005	-50.00%	1.00K
Vertiqal Studios	0.01	-50.00%	40.00K
CryptoStar	0.0050	-50.00%	113.49K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
MDA	48.68	-3.05%	916.31K
Keel Infra	6.57	-4.09%	2.04M
Toronto Dominion Bank	169.29	+0.43%	1.86M
TELUS	14.75	-0.10%	1.84M
Aritzia	159.22	+6.87%	1.14M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaaaaaa	6.71	+59.12%	10.68
Aaa Aaaaa A Aaaaa A	95.21	+53.07%	145.74
Aaaaa Aaaaa Aaa	5.34	+52.51%	8.14
Aaaaaaaaaa	135.73	+48.82%	201.99
Aaaaaaaa Aaa	16.46	+45.37%	23.93
Aaaaaa	21.69	+44.83%	31.41
A Aaa	5.41	+42.60%	7.71

Name	Last	Upside	Fair Value
Aaaaa Aaaaaaaa	6.71	+59.12%	10.68
Aaa Aaaaa A Aaaaa A	95.21	+53.07%	145.74
Aaaaa Aaaaa Aaa	5.34	+52.51%	8.14
Aaaaaaaaaa	135.73	+48.82%	201.99
Aaaaaaaa Aaa	16.46	+45.37%	23.93
Aaaaaa	21.69	+44.83%	31.41
A Aaa	5.41	+42.60%	7.71

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

BioLargo Inc (BLGO)

BLGO Income Statement

FAQ

What was BioLargo’s revenue at year end?

How much revenue did BioLargo report in the most recent quarter?

What was BioLargo’s net income for the year?

How much net income did BioLargo post in the last quarter?

What was BioLargo’s gross profit for the year?

How much gross profit did BioLargo generate last quarter?

What was BioLargo’s annual operating income?

What was BioLargo’s operating income last quarter?

What was BioLargo’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for BioLargo?

What is BioLargo’s most recent gross profit margin?

What is BioLargo’s most recent net income margin?

What is BioLargo’s most recent EBIT margin?

How did BioLargo’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for BioLargo?

Trending Stocks